Antidepressant therapy in coronary artery disease;Antidepressive therapie bei koronarer herzkrankheit

Nervenarzt

Volumn 82, Issue 5, 2011, Pages 657-666

  Lange Asschenfeldt, C ^a   Lederbogen, F ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

Antidepressive Agents; Cardiovascular risk; Coronary artery disease; Depression; Mortality

Indexed keywords

ANTIDEPRESSANT AGENT;

COMORBIDITY; CORONARY ARTERY DISEASE; DEPRESSION; HUMAN; PSYCHOTHERAPY; REVIEW; RISK BENEFIT ANALYSIS;

ANTIDEPRESSIVE AGENTS; COMBINED MODALITY THERAPY; COMORBIDITY; CORONARY DISEASE; DEPRESSIVE DISORDER, MAJOR; EVIDENCE-BASED MEDICINE; HUMANS; LIFE STYLE; PSYCHOTHERAPY; RISK FACTORS; SURVIVAL RATE;

EID: 79960034735     PISSN: 00282804     EISSN: 14330407     Source Type: Journal    
DOI: 10.1007/s00115-010-3181-7     Document Type: Review

References (29)

1. Appels A, Bar FW, Bar J et al (2000) Inflammation, depressive symptomtology, and coronary artery disease. Psychosom Med 62(5):601-605
2. Carney RM, Blumenthal JA, Freedland KE et al (2004) Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. Psychosom Med 66(4):466-474 (Pubitemid 38971239)
3. Carney RM, Blumenthal JA, Catellier D et al (2003) Depression as a risk factor for mortality after acute myocardial infarction. Am J Cardiol 92(11):1277-1281 (Pubitemid 37431134)
4. Chrapko WE, Jurasz P, Radomski MW et al (2004) Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder. Biol Psychiatry 56(2):129-134 (Pubitemid 38844788)
5. Davidson KW, Rieckmann N, Clemow L et al (2010) Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms: coronary psychosocial evaluation studies randomized controlled trial. Arch Intern Med 170(7):600-608
6. Jonge P de, Honig A, Melle JP van et al (2007) Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events. Am J Psychiatry 164(9):1371-1378 (Pubitemid 47461137)
7. Deuschle M, Lederbogen F (2002) Depression and cardiovascular disease: pathogenetic factors of the stress concept. Fortschr Neurol Psychiatr 70(5):268-275 (Pubitemid 34601744)
8. Everson-Rose SA, Lewis TT (2005) Psychosocial factors and cardiovascular diseases. Annu Rev Public Health 26:469-500 (Pubitemid 40547393)
9. Frasure-Smith N, Lesperance F, Talajic M (1995) Depression and 18-month prognosis after myocardial infarction. Circulation 91(4):999-1005
10. Frasure-Smith N, Lesperance F, Talajic M (1993) Depression following myocardial infarction. Impact on 6-month survival. JAMA 270(15):1819-1825
11. Glassman AH, Bigger JT Jr, Gaffney M (2009) Psychiatric characteristics associated with long-term mortality among 361 patients having an acute coronary syndrome and major depression: seven-year follow-up of SADHART participants. Arch Gen Psychiatry 66(9):1022-1029
12. Glassman AH, O'Connor CM, Califf RM et al (2002) Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 288(6):701-709 (Pubitemid 34848222)
13. Glazer KM, Emery CF, Frid DJ, Banyasz RE (2002) Psychological predictors of adherence and outcomes among patients in cardiac rehabilitation. J Cardiopulm Rehabil 22(1):40-46
14. Herrmann-Lingen C, Albus C, Titscher G (2008) Psychokardiologie. Ein Praxisleitfaden für Ärzte und Psychologen. Deutscher Ärzte, Köln
15. Howren MB, Lamkin DM, Suls J (2009) Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 71(2):171-186
16. Ladwig KH, Lederbogen F, Völler H et al (2008) Positionspapier zur Bedeutung von psychosozialen Faktoren in der Kardiologie. Kardiologe 2:274-287
17. Lederbogen F, Gilles M, Maras A et al (2001) Increased platelet aggregability in major depression? Psychiatry Res 102(3):255-261
18. Lesperance F, Frasure-Smith N, Koszycki D et al (2007) Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA 297(4):367-379 (Pubitemid 46155798)
19. Lichtman JH, Bigger JT Jr, Blumenthal JA et al (2008) Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation 118(17):1768-1775
20. Manev H, Manev R (2007) 5-lipoxygenase as a possible biological link between depressive symptoms and atherosclerosis. Arch Gen Psychiatry 64(11):1333 (Pubitemid 350074832)
21. Mayer AF, Schroeder C, Heusser K et al (2006) Influences of norepinephrine transporter function on the distribution of sympathetic activity in humans. Hypertension 48(1):120-126 (Pubitemid 44297533)
22. Musselman DL, Betan E, Larsen H, Phillips LS (2003) Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry 54(3):317-329 (Pubitemid 37267861)
23. Rajagopalan S, Brook R, Rubenfire M et al (2001) Abnormal brachial artery flow-mediated vasodilation in young adults with major depression. Am J Cardiol 88(2):196-198, A7
24. Roose SP, Laghrissi-Thode F, Kennedy JS et al (1998) Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA 279(4):287-291 (Pubitemid 28071019)
25. Roose SP, Glassman AH, Dalack GW (1989) Depression, heart disease, and tricyclic antidepressants. J Clin Psychiatry 50 (Suppl):12-16 (Pubitemid 19193455)
26. Ruo B, Rumsfeld JS, Hlatky MA etal (2003) Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA 290(2):215-221 (Pubitemid 37430060)
27. Sherwood A, Hinderliter AL, Watkins LL et al (2005) Impaired endothelial function in coronary heart disease patients with depressive symptomatology. J Am Coll Cardiol 46(4):656-659 (Pubitemid 41132693)
28. Melle JP van, Jonge P de, Honig A et al (2007) Effects of antidepressant treatment following myocardial infarction. Br J Psychiatry 190:460-466 (Pubitemid 46868827)
29. Wernicke JF, Prakash A, Kajdasz DK, Houston J (2009) Safety and tolerability of duloxetine treatment of diabetic peripheral neuropathic pain between patients with and without cardiovascular conditions. J Diabetes Complications 23:349-359